Ivan Arenas is a Cardiology physician affiliated with Salem Hospital. OpenAlex indexes 51 publications with 1,475 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
885 Mission St SE
Salem, OR 973026222
Telephone
503-814-0273Provider last certified this registry record 5 Nov 2021.
Clinical trials
- Seal Pressure With Classical Laryngeal Mask and Cookgas Mask in Adult Patients
Sponsor: Universidad de Antioquia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- PFIZER INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.4%Beta blocker19.2%Metoprolol Succinate60%Carvedilol24%Metoprolol Tartrate12%Atenolol2%Bisoprolol Fumarate2%Part D<11 patientsStatin11.3%Atorvastatin Calcium43%Rosuvastatin Calcium31%Pravastatin Sodium22%Simvastatin4%Part D<11 patients+ 13 more classes in this area
Blood & clotting
11.6%Factor Xa inhibitor8.7%Eliquis92%Xarelto8%Part D<11 patientsP2Y12 inhibitor2.4%Clopidogrel76%Brilinta24%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
7%SGLT2 inhibitor6.2%Farxiga68%Jardiance32%Part D≥30 patientsPotassium supplement0.8%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”